{"id":34367,"date":"2025-05-28T17:12:54","date_gmt":"2025-05-28T09:12:54","guid":{"rendered":"https:\/\/flcube.com\/?p=34367"},"modified":"2025-05-28T17:12:55","modified_gmt":"2025-05-28T09:12:55","slug":"guided-therapeutics-receives-payment-from-shandong-yaohua-for-luviva-commercialization","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=34367","title":{"rendered":"Guided Therapeutics Receives Payment from Shandong Yaohua for LuViva Commercialization"},"content":{"rendered":"\n

US-based Guided Therapeutics, Inc. (OTCMKTS: GTHP<\/a>), a developer of rapid, painless testing platforms based on patented biophotonic technology, announced it has received a USD 100,000 payment from China’s Shandong Yaohua Medical Instrument Corporation (SMI) through an investment partner. This payment marks the first in a series of planned transactions aimed at extending the collaboration agreement between GTHP and SMI. The goal is to commercialize the LuViva Advanced Cervical Scan in China following anticipated regulatory approval, expected by September 2025.<\/p>\n\n\n\n

LuViva Advanced Cervical Scan<\/strong>
LuViva, Guided Therapeutics’ flagship product, is a non-invasive device designed to detect cervical disease instantly and at the point of care. In a multicenter clinical trial involving high-risk women, LuViva demonstrated the ability to detect cervical cancer up to two years earlier than conventional methods. This innovation underscores the potential of biophotonic technology in advancing early disease detection.<\/p>\n\n\n\n

Clinical Trial and Regulatory Progress<\/strong>
SMI, Guided Therapeutics’ exclusive manufacturing and distribution partner in China, completed LuViva’s regulatory clinical trial in November 2023. The trial data was released in April 2024. Guided Therapeutics is now focused on securing the necessary regulatory approvals to bring this groundbreaking technology to the Chinese market.-Fineline Info & Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

US-based Guided Therapeutics, Inc. (OTCMKTS: GTHP), a developer of rapid, painless testing platforms based on…<\/p>\n","protected":false},"author":1,"featured_media":34371,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[16,4107,4108,4109],"class_list":["post-34367","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-cancer","tag-guided-therapeutics","tag-otcmkts-gthp","tag-yaohua-medical-instrument"],"yoast_head":"\nGuided Therapeutics Receives Payment from Shandong Yaohua for LuViva Commercialization - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"US-based Guided Therapeutics, Inc. (OTCMKTS: GTHP), a developer of rapid, painless testing platforms based on patented biophotonic technology, announced it has received a USD 100,000 payment from China's Shandong Yaohua Medical Instrument Corporation (SMI) through an investment partner. This payment marks the first in a series of planned transactions aimed at extending the collaboration agreement between GTHP and SMI. The goal is to commercialize the LuViva Advanced Cervical Scan in China following anticipated regulatory approval, expected by September 2025.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=34367\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Guided Therapeutics Receives Payment from Shandong Yaohua for LuViva Commercialization\" \/>\n<meta property=\"og:description\" content=\"US-based Guided Therapeutics, Inc. (OTCMKTS: GTHP), a developer of rapid, painless testing platforms based on patented biophotonic technology, announced it has received a USD 100,000 payment from China's Shandong Yaohua Medical Instrument Corporation (SMI) through an investment partner. This payment marks the first in a series of planned transactions aimed at extending the collaboration agreement between GTHP and SMI. The goal is to commercialize the LuViva Advanced Cervical Scan in China following anticipated regulatory approval, expected by September 2025.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=34367\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-28T09:12:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-28T09:12:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2823.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34367#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34367\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Guided Therapeutics Receives Payment from Shandong Yaohua for LuViva Commercialization\",\"datePublished\":\"2025-05-28T09:12:54+00:00\",\"dateModified\":\"2025-05-28T09:12:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34367\"},\"wordCount\":204,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34367#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/2823.webp\",\"keywords\":[\"Cancer\",\"Guided Therapeutics\",\"OTCMKTS: GTHP\",\"Yaohua Medical Instrument\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=34367#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34367\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=34367\",\"name\":\"Guided Therapeutics Receives Payment from Shandong Yaohua for LuViva Commercialization - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34367#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34367#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/2823.webp\",\"datePublished\":\"2025-05-28T09:12:54+00:00\",\"dateModified\":\"2025-05-28T09:12:55+00:00\",\"description\":\"US-based Guided Therapeutics, Inc. (OTCMKTS: GTHP), a developer of rapid, painless testing platforms based on patented biophotonic technology, announced it has received a USD 100,000 payment from China's Shandong Yaohua Medical Instrument Corporation (SMI) through an investment partner. This payment marks the first in a series of planned transactions aimed at extending the collaboration agreement between GTHP and SMI. The goal is to commercialize the LuViva Advanced Cervical Scan in China following anticipated regulatory approval, expected by September 2025.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34367#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=34367\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34367#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/2823.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/2823.webp\",\"width\":1080,\"height\":608,\"caption\":\"Explore the latest insights on Yaohua Medical Instrument and its impact on China's pharmaceutical industry. Fineline Info & Tech delivers reliable data, news, and intelligence to help you navigate the complexities of Yaohua Medical Instrument's developments with precision and clarity. Stay informed and enhance your decision-making at flcube.com.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=34367#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Guided Therapeutics Receives Payment from Shandong Yaohua for LuViva Commercialization\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Guided Therapeutics Receives Payment from Shandong Yaohua for LuViva Commercialization - Insight, China's Pharmaceutical Industry","description":"US-based Guided Therapeutics, Inc. (OTCMKTS: GTHP), a developer of rapid, painless testing platforms based on patented biophotonic technology, announced it has received a USD 100,000 payment from China's Shandong Yaohua Medical Instrument Corporation (SMI) through an investment partner. This payment marks the first in a series of planned transactions aimed at extending the collaboration agreement between GTHP and SMI. The goal is to commercialize the LuViva Advanced Cervical Scan in China following anticipated regulatory approval, expected by September 2025.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=34367","og_locale":"en_US","og_type":"article","og_title":"Guided Therapeutics Receives Payment from Shandong Yaohua for LuViva Commercialization","og_description":"US-based Guided Therapeutics, Inc. (OTCMKTS: GTHP), a developer of rapid, painless testing platforms based on patented biophotonic technology, announced it has received a USD 100,000 payment from China's Shandong Yaohua Medical Instrument Corporation (SMI) through an investment partner. This payment marks the first in a series of planned transactions aimed at extending the collaboration agreement between GTHP and SMI. The goal is to commercialize the LuViva Advanced Cervical Scan in China following anticipated regulatory approval, expected by September 2025.","og_url":"https:\/\/flcube.com\/?p=34367","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-05-28T09:12:54+00:00","article_modified_time":"2025-05-28T09:12:55+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2823.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=34367#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=34367"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Guided Therapeutics Receives Payment from Shandong Yaohua for LuViva Commercialization","datePublished":"2025-05-28T09:12:54+00:00","dateModified":"2025-05-28T09:12:55+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=34367"},"wordCount":204,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=34367#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2823.webp","keywords":["Cancer","Guided Therapeutics","OTCMKTS: GTHP","Yaohua Medical Instrument"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=34367#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=34367","url":"https:\/\/flcube.com\/?p=34367","name":"Guided Therapeutics Receives Payment from Shandong Yaohua for LuViva Commercialization - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=34367#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=34367#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2823.webp","datePublished":"2025-05-28T09:12:54+00:00","dateModified":"2025-05-28T09:12:55+00:00","description":"US-based Guided Therapeutics, Inc. (OTCMKTS: GTHP), a developer of rapid, painless testing platforms based on patented biophotonic technology, announced it has received a USD 100,000 payment from China's Shandong Yaohua Medical Instrument Corporation (SMI) through an investment partner. This payment marks the first in a series of planned transactions aimed at extending the collaboration agreement between GTHP and SMI. The goal is to commercialize the LuViva Advanced Cervical Scan in China following anticipated regulatory approval, expected by September 2025.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=34367#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=34367"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=34367#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2823.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2823.webp","width":1080,"height":608,"caption":"Explore the latest insights on Yaohua Medical Instrument and its impact on China's pharmaceutical industry. Fineline Info & Tech delivers reliable data, news, and intelligence to help you navigate the complexities of Yaohua Medical Instrument's developments with precision and clarity. Stay informed and enhance your decision-making at flcube.com."},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=34367#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Guided Therapeutics Receives Payment from Shandong Yaohua for LuViva Commercialization"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/05\/2823.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/34367","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=34367"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/34367\/revisions"}],"predecessor-version":[{"id":34372,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/34367\/revisions\/34372"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/34371"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=34367"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=34367"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=34367"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}